These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Iron Mapping in Multiple Sclerosis. Ropele S, Enzinger C, Fazekas F. Neuroimaging Clin N Am; 2017 May; 27(2):335-342. PubMed ID: 28391790 [Abstract] [Full Text] [Related]
44. Iron and neurodegeneration in the multiple sclerosis brain. Hametner S, Wimmer I, Haider L, Pfeifenbring S, Brück W, Lassmann H. Ann Neurol; 2013 Dec; 74(6):848-61. PubMed ID: 23868451 [Abstract] [Full Text] [Related]
46. Iron and multiple sclerosis. Stankiewicz JM, Neema M, Ceccarelli A. Neurobiol Aging; 2014 Sep; 35 Suppl 2():S51-8. PubMed ID: 24929968 [Abstract] [Full Text] [Related]
47. Iron Heterogeneity in Early Active Multiple Sclerosis Lesions. Tham M, Frischer JM, Weigand SD, Fitz-Gibbon PD, Webb SM, Guo Y, Adiele RC, Robinson CA, Brück W, Lassmann H, Furber KL, Pushie MJ, Parisi JE, Lucchinetti CF, Popescu BF. Ann Neurol; 2021 Mar; 89(3):498-510. PubMed ID: 33244761 [Abstract] [Full Text] [Related]
48. Multiple sclerosis and amyloid deposits in the white matter of the brain. Nennesmo I, Bogdanovic N, Petrén AL, Fredrikson S. Acta Neuropathol; 1997 Feb; 93(2):205-9. PubMed ID: 9039470 [Abstract] [Full Text] [Related]
50. Iron deposition is independent of cellular inflammation in a cerebral model of multiple sclerosis. Williams R, Rohr AM, Wang WT, Choi IY, Lee P, Berman NE, Lynch SG, LeVine SM. BMC Neurosci; 2011 Jun 23; 12():59. PubMed ID: 21699685 [Abstract] [Full Text] [Related]
51. Nuclear prelamin a recognition factor and iron dysregulation in multiple sclerosis. Ding D, Valdivia AO, Bhattacharya SK. Metab Brain Dis; 2020 Feb 23; 35(2):275-282. PubMed ID: 31823109 [Abstract] [Full Text] [Related]
52. Neurogenesis in the chronic lesions of multiple sclerosis. Chang A, Smith MC, Yin X, Fox RJ, Staugaitis SM, Trapp BD. Brain; 2008 Sep 23; 131(Pt 9):2366-75. PubMed ID: 18669500 [Abstract] [Full Text] [Related]
53. Trajectories of subcortical iron accumulation in MS. Rovira À, Wiggermann V, Rauscher A. Neurology; 2015 Jun 16; 84(24):2388-9. PubMed ID: 25979699 [No Abstract] [Full Text] [Related]
54. Pathogenic implications of iron accumulation in multiple sclerosis. Williams R, Buchheit CL, Berman NE, LeVine SM. J Neurochem; 2012 Jan 16; 120(1):7-25. PubMed ID: 22004421 [Abstract] [Full Text] [Related]
55. [Fatty acid composition of cholesterol esters of the cerebral white substance in multiple sclerosis. (Preliminary note)]. Borri PF, Bertinelli RP, Toso V, Taramelli M, Paci M, Pacini A. Acta Neurol (Napoli); 1969 Jan 16; 24(4):593-602. PubMed ID: 5402754 [No Abstract] [Full Text] [Related]
56. CT detection of demyelinated plaques in multiple sclerosis. Haughton VM, Ho KC, Williams AL, Eldevik OP. AJR Am J Roentgenol; 1979 Feb 16; 132(2):213-5. PubMed ID: 105586 [Abstract] [Full Text] [Related]
57. [An autopsy case of multiple sclerosis]. Hattori S, Tanaka S, Nakajima T, Akima M, Fukunaga N. Rinsho Shinkeigaku; 1988 Jan 16; 28(1):32-6. PubMed ID: 3383511 [No Abstract] [Full Text] [Related]
58. Acute multiple sclerosis - report of a case with neuropathological and neurochemical studies. Banerjee AK, Chopra JS, Kumar BR. Neurol India; 1977 Dec 16; 25(4):233-7. PubMed ID: 614511 [No Abstract] [Full Text] [Related]
59. MR brain iron mapping in MS: a potential neurodegenerative marker or just another technique? Rovira A, Montalban X. Neurology; 2011 Nov 01; 77(18):1660-1. PubMed ID: 21975201 [No Abstract] [Full Text] [Related]
60. [Autopsy study of acute multiple sclerosis]. Furumi K, Mori K, Takeoka T, Ogawa Y, Matsuyama H. Rinsho Shinkeigaku; 1975 Apr 01; 15(4):199-204. PubMed ID: 1170058 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]